Birdwatch Note Rating
2023-04-09 14:21:31 UTC - HELPFUL
Rated by Participant: B4B3926299AD9D80E40C742DC5D49723DD883AF7E066104BD71112D1736265BF
Participant Details
Original Note:
The suspension of approval of the drug has to do with safety concerns, and the government has time to appeal the decision. "The Court does not second-guess FDA’s decision-making lightly," Kacsmaryk wrote. "But here, FDA acquiesced on its legitimate safety concerns” https://www.nbcnews.com/news/us-news/abortion-pill-case-texas-judge-halts-access-mifepristone-rcna72117
All Note Details